Incidence and characteristics of newly diagnosed rheumatic heart disease in Urban African adults: Insights from the Heart of Soweto Study

European Heart Journal

Volumn 31, Issue 6, 2010, Pages 719-727

  Sliwa, Karen ^a   Carrington, Melinda ^a,d   Mayosi, Bongani M ^c   Zigiriadis, Elias ^b   Mvungi, Robert ^a   Stewart, Simon ^a,d  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

^d BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

Africa; Epidemiologic transition; Rheumatic heart disease; Valve disease

Indexed keywords

ACETYLSALICYLIC ACID; ALDOSTERONE ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CARDIAC GLYCOSIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOOP DIURETIC AGENT; POTASSIUM; WARFARIN;

ADOLESCENT; ADULT; AFRICA; AGED; ANEMIA; AORTA VALVE REGURGITATION; ARTICLE; BACTERIAL ENDOCARDITIS; ECHOCARDIOGRAPHY; FEMALE; GROUPS BY AGE; HEART ATRIUM FIBRILLATION; HEART VALVE REPLACEMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PRIORITY JOURNAL; RHEUMATIC HEART DISEASE; SYSTOLIC BLOOD PRESSURE; SYSTOLIC DYSFUNCTION; URBAN POPULATION; VALVULAR HEART DISEASE;

ADOLESCENT; ADULT; AGED; CALCINOSIS; ECHOCARDIOGRAPHY; FEMALE; HEART VALVE DISEASES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROGNOSIS; RHEUMATIC HEART DISEASE; RISK FACTORS; SOUTH AFRICA; URBAN HEALTH; YOUNG ADULT;

EID: 77954146419     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehp530     Document Type: Article

References (31)

1. Carapetis JR. The Current Evidence of the Burden of Group A Streptococcal Disease. Geneva: World Health Organization; 2004. p1-57.
2. Carapetis JR, Steer AC, Mulholland EK, Weber M. The global burden of group A streptococcal diseases. Lancet Infect Dis 5:685-694.
3. Carapetis JR. Rheumatic heart disease in developing countries. N Engl J Med 2007; 357:439-441.
4. Sliwa K, Wilkinson D, Hansen C, Ntyinyane L, Tibazarwa K, Becker A, Stewart S. A broad spectrum of heart disease and risk factors in a black urban population in South Africa: results from The Heart of Soweto Study Clinical Registry. Lancet 2008;371:915-922.
5. Stewart S, Wilkinson D, Hansen C, Vaghela J, Mvungi R, McMurray J, Sliwa K. A predominance of heart failure in the Heart of Soweto cohort: emerging challenges for an African cohort. Circulation 2008;118:2360-2367.
6. Mayosi BM, Robertson K, Volmink J. The Drakensberg Declaration on the control of rheumatic fever and rheumatic heart disease in Africa. S Afr Med J 2006;96:246.
7. Robertson KA, Volmink JA, Mayosi BM. Towards a uniform plan for the control of rheumatic fever and rheumatic heart disease in Africa-the Awareness Surveillance Advocacy Prevention (ASAP) Programme. S Afr Med J 2006;96:241-245.
8. Stewart S, Wilkinson D, Becker A, Askew D, Ntyintyane L, McMurray JJ, Sliwa K. Mapping the emergence of heart disease in a black, urban population in Africa: The Heart of Soweto Study. Int J Cardiol 2006;101:101-108.
9. Tibazarwa K, Ntyintyane L, Sliwa K, Gerntholtz T, Carrington M, Wilkinson D, Stewart S. A time bomb of cardiovascular risk factors in South Africa: results from the Heart of Soweto Study 'Heart Awareness Days'. Int J Cardiol 2008; doi:10.1016/j.ijcard.2007.11.067.
10. Prineas RJ, Crow RS, Blackburn H. The Minnesota Code Manual of Electrocardio-graphic Findings: Standards and Procedures for Measurement and Classification. Boston, MA: John Wright; 1982.
11. Sahn DJ, DeMaria A, Kisslo J, Weyman A. The Committee on M-mode Standardization of the American Society of Echocardiography. Recommendations regarding quantification in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978;58:1072-1083.
12. Otto CM. Valvular stenosis and valvular regurgitation. In: Otto CM (ed.), Textbook of Clinical Echocardiography. 3rd edn. Elsevier Saunders; 2004. p281-328.
13. Mylonakis E, Calderwood SB. Infective endocarditis in adults. N Engl J Med 2001; 345:1318-1330.
14. Tibazarwa KB, Volmink JA, Mayosi BM. Incidence of rheumatic fever in the world: a systematic review of population-based studies. Heart 2008;94: 1534-1540.
15. Clur SA. Frequency and severity of rheumatic heart disease in the catchment area of gauteng hospitals, 1993-1995. S Afr Med J 2006;96:233-237. [part 2].
16. Carapetis JR, McDonald M, Wilson NJ. Acute rheumatic fever. Lancet 2006;366: 155-168.
17. Essop MR, Wisenbaugh T, Sareli P. Evidence against a myocardial factor as a cause of ventricular dilatation in active rheumatic carditis. J Am Coll Cardiol 1993;22: 826-829.
18. Marijon E, Ou P, Celermajer D, Ferreira B, Mocumbi AO, Jani D, Paquet C, Jacob S, Sidi D, Jouven X. Prevalence of Rheumatic heart disease detected by echocardiographic screening. N Engl J Med 2007;357:470-476.
19. Nkgudi B, Robertson KA, Volmink JA, Mayosi BM. Notification of rheumatic fever in South Africa: evidence of under-reporting by health professionals and administrators. S Afr Med J 2006;95:206-208.
20. Komajda M, Lassus J, Lopez-Sendon JL, Ponikowski P, Tavazzi L, Nieminen MS, Brutsaert D, Dickstein K, Drexler H, Follath F, Harjola VP, Hochadel M, on behalf of the EuroHeart Survey Investigators. EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population. Eur Heart J 2006;27:2725-2736.
21. Nkomo V, Gardin JM, Skelton TN, Scott CG, Enriqez-Serano M. Burden of valvular heart disease: a population based study. Lancet 2006;368:1005-1011.
22. Ypenburg C, Lancellotti P, Tops LF, Boersma E, Bleeker GB, Holman ER, Thomas JD, Schalij MJ, Pierard LA, Bax JJ. Mechanism of improvement in mitral regurgitation after cardiac resynchronization therapy. Eur Heart J 2008;29: 757-765.
23. Perez de Isla L, Zamorano J, Quezada M, Almeria C, Rodrigo JL, Serra V, Rubira JCG, Ortiz AF, Macaya C. Functional mitral regurgitation alter first non-ST-segment elevation acute coronary syndrome: contribution to congestive heart failure. Eur Heart J 2007;28:2866-2872.
24. Nqayana T, Moodley J, Naidoo DP. Cardiac disease in pregnancy. Cardiovasc J Afr 2008;19:145-151.
25. Soma-Pillay P, Macdonald AP, Mathivha TM, Bakker JL, Mackintosh MO. Cardiac disease in pregnancy: a 4-year audit at Pretoria Academic Hospital. S Afr Med J 2008;98:553-556.
26. Sani M, Karaye K, Borodo MM. Prevalence and pattern of rheumatic heart disease in the Nigerian savannah:an echocardiographic study. Cardiovasc JAfr 2007;18:295-299.
27. von Elm E, Altman DG, Eggers M, Pocock S J, Gotzsche PC, Vandenbroucke JP, for the STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies. Bull WHO 2007;85:867-872. (Pubitemid 350086459)
28. Commerford P, Mayosi B. An appropriate research agenda for heart research in Africa. Lancet 2006;367:1884-1886.
29. Carapetis JR, Mayosi BM, Kaplan EL. Controlling rheumatic heart disease in developing countries. Cardiovasc J S Afr 2006;17:164-165.
30. Robertson KA, Mayosi BM. Rheumatic heart disease: social and economic dimensions. S Afr Med J 2008;98:780-781.
31. McDonald M, Brown A, Noonan S, Carapetis JR. Preventing recurrent rheumatic fever: the role of register based programmes. Heart 2005;91: 1131-1133.